Victor Wang

Victor Wang is a Partner at HOF Capital, a multi-stage venture capital firm with over $1B in assets under management, where the focus is on supporting ambitious founders in building generational companies. As an investor, Victor is involved with several innovative firms, including Extropic, which aims to revolutionize generative AI, and insitro, which utilizes AI and big data for drug discovery. Victor serves as the first VC investor and board observer for companies like Motion and StyleAI, the latter having achieved significant revenue growth shortly after its launch. With a strong background in scientific research obtained at the Stanford University School of Medicine, Victor holds a B.A. in Molecular & Cell Biology from the University of California, Berkeley.